Researchers develop a new drug to combat the measles

April 16, 2014, Georgia State University

A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says.

Scientists from the Institute for Biomedical Sciences at Georgia State University, the Emory Institute for Drug Development and the Paul-Ehrlich Institute in Germany developed the and tested it in animals infected with a closely related to one that causes the . As reported in the current issue of the journal Science Translational Medicine, virus levels were significantly reduced when infected animals received the drug by mouth. The drug also prevented the animals from dying of the disease.

This drug, one that can be produced cost-effectively, stockpiled and administered by mouth, could boost eradication efforts by rapidly suppressing the spread of the virus during local outbreaks.

Despite major progress in controlling the measles worldwide, annual measles deaths have remained constant at around 150,000 since 2007, and there has been a resurgence of the virus in European countries where it had been considered controlled. The reasons for this are the highly infectious nature of the virus and insufficient vaccine coverage, which in the developed world is mostly due to parents opting not to vaccinate their children.

Dr. Richard Plemper, from the newly founded Institute for Biomedical Sciences at Georgia State University, and his colleagues at the Emory Institute for Drug Discovery (EIDD) have developed a drug, termed ERDRP-0519, which blocks the replication of the pathogen.

"We are delighted to see our long-standing collaboration with Dr. Plemper and his team at the GSU IBMS come to fruition, and we look forward to continuing to leverage the medicinal chemistry and capabilities at the EIDD in this and future collaborations with his group," said Dr. Michael Natchus, director of operations at the EIDD.

In collaboration with Dr. Veronika von Messling from the Paul-Ehrlich-Institute, the researchers tested the drug by turning to a virus very closely related to measles virus, the canine distemper virus, which causes a highly lethal infection in ferrets. All of the animals treated with ERDRP-0519 survived infection with the distemper virus, remained disease free and developed robust immunity against the virus.

Dr. Plemper said the drug could be used to treat friends, family and other social contacts of a person infected with , who have not developed symptoms yet but are at risk of having caught the disease.

"The emergence of strong antiviral immunity in treated animals is particularly encouraging, since it suggests that the drug may not only save an infected individual from disease but contribute to closing measles immunity gaps in a population," Dr. Plemper said.

The researchers emphasize the drug is not intended as a substitute for vaccination, but as an additional weapon in a concerted effort to eliminate the measles.

As experienced with many antiviral drugs, the virus can become resistant against this inhibitor. The investigators have examined the issue of viral escape and found that resistant viruses were in most cases less virulent. Equally important, the researchers observed that transmission of the resistant viruses between animals was impaired compared to the parent strain. These results are promising because they indicate resistance is unlikely to rapidly become widespread in the virus population.

While the drug is very encouraging thus far, additional research is needed before it could be considered for use in humans.

Explore further: Researchers find that influenza has an Achilles' heel

More information: Krumm SA, Yan D, Hovingh E, Evers TJ, Enkirch T, Reddy GP, Sun A, Saindane MT, Arrendale RF, Painter G, Liotta DC, Natchus MG, von Messling V, Plemper RK (2014). Orally Available Small-Molecule Polymerase Inhibitor Cures a Lethal Morbillivirus Infection. Science Translational Medicine, 2014.

Related Stories

Researchers find that influenza has an Achilles' heel

April 10, 2014
Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study published by Cell Press on April 10 in the journal ...

California officials warn of measles exposure

February 14, 2014
San Francisco Bay Area officials say a University of California, Berkeley, student infected with measles could have exposed thousands of others by attending classes and riding public transit.

Infected traveller sparks New Zealand measles alert

January 15, 2014
New Zealand health authorities were trying to track down hundreds of passengers on Wednesday who may have been exposed to measles on a Singapore Airlines flight at the weekend.

Man dies as UK measles epidemic spreads

April 19, 2013
U.K. authorities say a 25-year-old man is suspected to have died from measles as an epidemic continues to sweep across south Wales.

Measles cases linked to US adoptions of Chinese children, CDC reports

April 10, 2014
(HealthDay)—A series of measles cases in the United States involving children adopted from China highlights the importance of vaccinations for any adopted child from overseas, a new report reveals.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.